Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Zijn fluorochinolonen of macroliden beter voor de behandeling van Legionella-pneumonie?
aug 2021 | Bacteriële infecties, Pneumonie